Quality Investor

Cadre Holdings, Inc.

Rank #241Capital Return

CDRE · NYSE · Industrials

Cadre Holdings, Inc. (CDRE) — Rank #241 by gross profitability (GP/assets 0.28) · ROE 12.7% · Piotroski F-Score 6 / 9.

As-of 2026-09-15 · CIK 0001860543 · all metrics point-in-time as of the filing date.

About

Cadre Holdings, Inc. manufactures and distributes safety equipment and other related products that provides protection to users in hazardous or life-threatening situations in the United States and internationally.

Show more

It operates through two segments, Product and Distribution. The company offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. It also provides third-party products, such as uniforms, optics, boots, firearms, and ammunition. In addition, the company designs, manufactures and services equipment, vessels, precision components and remote handling systems for the nuclear, defence, and oil and gas industries. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies, including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, and various foreign government agencies. The company sells its products through its direct sales force, distribution channels and distribution partners/agents, online stores, and third-party resellers. Cadre Holdings, Inc.

was founded in 1964 and is headquartered in Jacksonville, Florida.

Industry
Aerospace & Defense
Sector
Industrials
State
DE
Filer Category
Emerging growth company
Fiscal Year End
December 31

Price History

CDRE+98.6% · +15.3% CAGRSPY+74.6% · +12.2% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$1.17B

P/E (annual)

26.8

P/S (annual)

1.9

P/B

3.4

P/OCF (annual)

18.4

Shareholder Yield

-6.4%

Employees

2,533

Industry

Aerospace & Defense

Exchange

NYSE

Signal Flags

3 green2 yellow2 red
Deferred revenue growingRevenue and deferred revenue both growing — retention signal
RPO outpacing revenueRemaining performance obligations growing faster than recognized revenue — forward demand building
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Dilution above 2%Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation
Disclosure regressionA previously-disclosed line item is no longer reported — worth checking the filing for why
Operating margin decliningOperating margin lower than prior year
Balance sheet deterioratingNet cash collapsed with receivables or inventory outpacing revenue

Quality Profile

Profitability

1/1 pass
GP / assets
0.28
Return on equity
12.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.65
Current ratio
2.14×
Net cash
-$320.35M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
2.0%

Growth

1/2 pass
Revenue growth
7.5%
Piotroski F-Score
6 / 9
Share dilution
7.7%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

1 of 5 threshold not computable from filed data.

What Growth Is Priced In

Implied revenue growth (10Y)

8.3%

incredible deal

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Dilution drag: 7.7% — per-share value needs a total required return of 16.0% once share-count change is priced in.

vs. own 6-year median revenue growth: 6.4%

within its own history

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

4.0%

r = 10% (base)

8.3%

r = 12%

12.1%

Net debt / market cap: 26.9%

Base FCF: $56.8M3Y mean FCF: $49.8M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

39.9xFair
16.3xmed 39.2x123.0x

P / S

Price / revenue per share

2.9xExpensive
1.5xmed 2.0x3.1x

P / B

Price / book value per share

5.6xFair
4.3xmed 6.5x70.8x

P / GP

Price / gross profit per share

6.8xExpensive
3.8xmed 4.9x7.4x

P / FCF

Price / free cash flow per share

31.1xExpensive
15.4xmed 19.9x51.8x

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.28

Primary signal (Novy-Marx).

42nd pctl of 37 SIC 38 peers

Return on equity

12.7%

Gross margin

42.5%

28th pctl of 37 SIC 38 peers

Revenue growth (YoY)

7.5%

RPO growth (YoY)

60.8%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

10.1%

Revenue CAGR (5Y)

8.6%

Earnings CAGR (3Y)

96.5%

FCF CAGR (3Y)

10.7%

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.65

6th pctl of 35 SIC 38 peers (best = lowest)

Current ratio

2.14×

37th pctl of 36 SIC 38 peers

Quick ratio

1.12×

Net cash

-$320.35M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$56.85M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

0.29

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

2.0%

Stock-based comp intensity.

Dividend safety

Composite score

3.0 / 5

Good
Payout ratio
35.0%4/5 Strong
FCF coverage
3.68×5/5 Strong
Dividend growth streak
3 yr2/5 Fair
Balance-sheet health
D/E 1.65 · IC N/A1/5 Weak

Piotroski F-Score

F-Score

6 / 9

Fundamental-strength score (0-9).

Lifecycle Phase History

20202025
Capital Return